Gilead Sciences: Caution After A Re-Rating Amidst New Concentration Risks (NASDAQ:GILD)

If you like to see more ideas, please subscribe to the Investing Group "Value in Corporate Events" here and try the free trial. In this service we cover major earnings events, M&A, IPOs and other significant corporate events with actionable ideas. Furthermore, we provide coverage of situations and names on request!Shares of Gilead Sciences ( GILD ) have been on a major run higher in recent years, far outperforming many peers that have been struggling. This made sense, as Gilead traded at very low valuations ...